Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen

Clinical Infectious Diseases

Volumn 42, Issue 4, 2006, Pages 451-459

  Sjostrom K ^a,c   Spindler, C ^b   Ortqvist, A ^b   Kalin, M ^b   Sandgren, A ^a,c   Kuhlmann Berenzon S ^a   Henriques Normark, Birgitta ^a,c  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL POLYSACCHARIDE; PENICILLIN DERIVATIVE;

ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; CANCER; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; FATALITY; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LIVER DISEASE; MAJOR CLINICAL STUDY; MOLECULAR TYPING; MORTALITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; OPPORTUNISTIC INFECTION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; BACTERIAL CAPSULES; BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CLONE CELLS; HEALTH STATUS INDICATORS; HUMANS; IMMUNITY, NATURAL; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 32044471320     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/499242     Document Type: Article

References (31)

1. Klein JO. Otitis media. Clin Infect Dis 1994; 19:823-33.
2. Bruyn GAW, van Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Clin Microbiol Infect Dis 1991; 10:897-910.
3. Ryan MW, Antonelli PJ. Pneumococcal antibiotic resistance and rates of meningitis in children. Laryngoscope 2000; 110:961-4.
4. Henriques Normark B, Christensson B, Sandgren A, et al. Clonal analysis of Streptococcus pneumoniae non-susceptible to penicillin at daycare centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers. Microb Drug Resist 2004; 9:337-44.
5. Nunes S, Sa-Leao R, Carrico J, et al. Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillance. J Clin Microbiol 2005; 43:1285-93.
6. Wood WB, Smith MR. The inhibition of surface phagocytosis by the capsular "slime layer" of pneumococcus type III. J Exp Med 1949; 90: 85-96.
7. Lindberg AA. Glycoprotein conjugate vaccines. Vaccine 1999; 17(Suppl 2):S28-36.
8. Henriques Normark B, M Kalin, A Ortqvist, et al. Dynamics of penicillin-susceptible clones in invasive pneumococcal disease. J Infect Dis 2001; 184:861-9.
9. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424-32.
10. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specifk properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis 2004; 189:785-96.
11. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190:1203-11.
12. Henriques B, Kalin M, Ortqvist A, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis 2000; 182:833-9.
13. Sandgren A, Albiger B, Orihuela C, Tuomanen E, Normark S, Henriques-Normark B. Virulence in mice of pneumococcal clonal types with known invasive disease potential in man. J Infect Dis 2005; 192: 791-800.
14. Kalin MA, Ortqvist M, Almela E, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis 2000; 182:840-7.
15. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. International Pneumococcal Study Group. Clin Infect Dis 2003; 37:230-7.
16. Watanakunakorn C, Bailey TA. Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996: a detailed analysis of 108 cases. Arch Intern Med 1997; 157:1965-71.
17. Olaechea PM, Quintana JM, Gallardo MS, Insausti J, Maravi E, Alvarez B. A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Intensive Care Med 1996; 22:1294-300.
18. Halbert SP, Swick L, Sonn C. The use of precipitin analysis in agar for the study of human streptococcal infections. II. Ouchterlony and Oakley technics. J Exp Med 1955; 101:557-76.
19. Lund E, Henrichsen J. Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. In: Bergan T, Norris JR, eds. Methods in microbiology. Vol 12. Academic Press: New York, 1978:241-62.
20. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995; 33:2759-62.
21. Olsson-Liljeqvist B, Larsson P, Walder M, Miorner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis Suppl 1997; 105:13-23.
22. Hermans PW, Sluijter M, Hoogenboezem T, Heersma H, van Belkum A, de Groot R. Comparative study of five different DNA fingerprint techniques for molecular typing of Streptococcus pneumoniae strains. J Clin Microbiol 1995; 33:1606-12.
23. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:2233-9.
24. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144:3049-60.
25. Multi Locus Sequence Typing. Available at: http://www.mlst.net. Accessed on 6 December 2005.
26. Conover WJ. Practical nonparametric statistics. New York: John Wiley & Sons, 1971.
27. Altman D. Practical statistics for medical research. Boca Raton: Chapman & Hall/CRC, 1991.
28. R Development Core Team, R. "R: A language and environment for statistical computing." Vienna, Austria: Foundation for Statistical Computing, 2005.
29. Normark BH, Ortqvist BA, Kalin M, et al. Changes in serotype distribution may hamper efficacy of pneumococcal conjugate vaccines in children. Scand J Inf Dis 2001; 33:848-50.
30. Hausdorff WP, Bryant J, Paradiso P, Siber G. Which pneumococcal serogroups casue the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-21.
31. Hava DL, Camilli A. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 2002; 45:1389-406.